268 related articles for article (PubMed ID: 16969385)
1. IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells.
Rosendahl AH; Forsberg G
Kidney Int; 2006 Nov; 70(9):1584-90. PubMed ID: 16969385
[TBL] [Abstract][Full Text] [Related]
2. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
Schedlich LJ; Yenson VM; Baxter RC
Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
[TBL] [Abstract][Full Text] [Related]
3. Influence of IGF-IR stimulation or blockade on proliferation of human renal cell carcinoma cell lines.
Rosendahl A; Forsberg G
Int J Oncol; 2004 Nov; 25(5):1327-36. PubMed ID: 15492822
[TBL] [Abstract][Full Text] [Related]
4. The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation.
Cheung CW; Vesey DA; Nicol DL; Johnson DW
Kidney Int; 2004 Apr; 65(4):1272-9. PubMed ID: 15086466
[TBL] [Abstract][Full Text] [Related]
5. Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.
Fukasawa H; Yamamoto T; Fujigaki Y; Misaki T; Ohashi N; Takayama T; Suzuki S; Mugiya S; Oda T; Uchida C; Kitagawa K; Hattori T; Hayashi H; Ozono S; Kitagawa M; Hishida A
Int J Cancer; 2010 Oct; 127(7):1517-25. PubMed ID: 20073064
[TBL] [Abstract][Full Text] [Related]
6. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells.
Kuemmerle JF; Murthy KS; Bowers JG
Am J Physiol Gastrointest Liver Physiol; 2004 Oct; 287(4):G795-802. PubMed ID: 15178549
[TBL] [Abstract][Full Text] [Related]
7. Altered messenger RNA and protein expressions for insulin-like growth factor family members in clear cell and papillary renal cell carcinomas.
Cheung C; Vesey D; Cotterill A; Douglas M; Gobe G; Nicol D; Johnson D
Int J Urol; 2005 Jan; 12(1):17-28. PubMed ID: 15661050
[TBL] [Abstract][Full Text] [Related]
8. Systemic IGF-I administration stimulates the in vivo growth of early, but not advanced, renal cell carcinoma.
Rosendahl AH; Holly JM; Celander M; Forsberg G
Int J Cancer; 2008 Sep; 123(6):1286-91. PubMed ID: 18561321
[TBL] [Abstract][Full Text] [Related]
9. Involvement of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in corneal fibroblasts during corneal wound healing.
Izumi K; Kurosaka D; Iwata T; Oguchi Y; Tanaka Y; Mashima Y; Tsubota K
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):591-8. PubMed ID: 16431955
[TBL] [Abstract][Full Text] [Related]
10. Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1.
Huang SS; Ling TY; Tseng WF; Huang YH; Tang FM; Leal SM; Huang JS
FASEB J; 2003 Nov; 17(14):2068-81. PubMed ID: 14597676
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta control of cell proliferation.
Huang SS; Huang JS
J Cell Biochem; 2005 Oct; 96(3):447-62. PubMed ID: 16088940
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-{beta} (TGF{beta}) receptors I/II differentially regulate TGF{beta}1 and IGF-binding protein-3 mitogenic effects in the human placenta.
Forbes K; Souquet B; Garside R; Aplin JD; Westwood M
Endocrinology; 2010 Apr; 151(4):1723-31. PubMed ID: 20172969
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor binding protein (IGFBP)-3 and IGFBP-5 mediate TGF-beta- and myostatin-induced suppression of proliferation in porcine embryonic myogenic cell cultures.
Kamanga-Sollo E; Pampusch MS; White ME; Hathaway MR; Dayton WR
Exp Cell Res; 2005 Nov; 311(1):167-76. PubMed ID: 16214131
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma.
Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD
Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292
[TBL] [Abstract][Full Text] [Related]
15. Signaling cross-talk between IGF-binding protein-3 and transforming growth factor-(beta) in mesenchymal chondroprogenitor cell growth.
O'Rear L; Longobardi L; Torello M; Law BK; Moses HL; Chiarelli F; Spagnoli A
J Mol Endocrinol; 2005 Jun; 34(3):723-37. PubMed ID: 15956343
[TBL] [Abstract][Full Text] [Related]
16. Effects of TGF-β signaling in clear cell renal cell carcinoma cells.
Boström AK; Lindgren D; Johansson ME; Axelson H
Biochem Biophys Res Commun; 2013 May; 435(1):126-33. PubMed ID: 23618868
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells.
Gucev ZS; Oh Y; Kelley KM; Rosenfeld RG
Cancer Res; 1996 Apr; 56(7):1545-50. PubMed ID: 8603400
[TBL] [Abstract][Full Text] [Related]
19. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-beta regulation of the insulin-like growth factor binding protein-4 protease system in cultured human osteoblasts.
Ortiz CO; Chen BK; Bale LK; Overgaard MT; Oxvig C; Conover CA
J Bone Miner Res; 2003 Jun; 18(6):1066-72. PubMed ID: 12817760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
